75. DMT for Depression with Dr Graham Campbell

Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week’s episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.

Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a range of topics. Discover his thoughts on the possibility of introducing psychedelic treatments by the NHS, the differences between magic mushrooms and DMT in the treatment of depression, and the crucial role of music in a psychedelic journey.

Join us for an engaging and informative discussion on the cutting-edge of psychedelic-assisted therapy, with one of the leading experts in the field. Don’t miss out – listen to our latest episode now!

Listen to Graham’s music here!


Psychedelic Assisted Therapy


Small Pharma


DMT


Ketamine


Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant


Schizophrenia


Bipolar disorder


Schizoaffective disorder


Trial of Psilocybin versus Escitalopram for Depression


Rosalind Watts


Michelle Baker Jones


Roberta Murphy 


Jonny Martell


Ashleigh Murphy-Beiner


Psilocybin


Institute of Psychedelic Therapy


The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy


Sussex Partnership NHS Foundation Trust


Ayahuasca


Monoamine oxidase inhibitor


Serotonin 


The ACE Model


The hidden therapist: evidence for a central role of music in psychedelic therapy


Max Cooper


Music and the Mind by Anthony Storr


Mind Foundation


Maria Papaspyrou